AstraZeneca acquires Hamilton-based pharmaceutical company Fusion

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

United States News News

United States United States Latest News,United States United States Headlines

A Canadian pharmaceutical company that focuses on developing next-generation therapies for prostate cancer has announced a definitive agreement to be acquired by U.K.-based AstraZeneca for approximately US$2.4 billion.

AstraZeneca acquires Hamilton-based pharmaceutical company FusionEQT CEO Warns Lack of Gas Storage Will Trigger Price GyrationsApollo Targets at Least $6 Billion for Third Hybrid Value FundAI Hype Hurts Emerging Markets, BTG Billionaire Esteves SaysUK Farmers to Drive Tractors to London to Protest Food PoliciesSupreme Court Allows Texas Deportation Law in Biden LossChina’s Builders Tackle Restructuring as Crisis Enters New PhaseMicrosoft Hires DeepMind Co-Founder Suleyman to Run Consumer AIUS...

6 ChargesSupreme Court Allows Texas Deportation Law in Biden LossTrump Says He Is ‘100%’ Behind NATO Allies Who Hit Spending GoalDoug Emhoff Decries ‘Antisemitic’ Trump Comments on Jewish DemocratsSenegal’s Sall Says Democracy Intact After Delayed Vote TurmoilBiden and Bibi Back Off Their Feud But Suspicion Lingers at HomeSouth African Investigators Raid Residence of Parliament SpeakerChinese Businessman Qin Hui Pleads Guilty to Straw Donor SchemeHunt Hints UK Government Looking at October for...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United States United States Latest News, United States United States Headlines